Back to News
Market Impact: 0.3

CNC Quantitative Stock Analysis

CNCNDAQ
Company FundamentalsAnalyst InsightsCorporate EarningsHealthcare & Biotech
CNC Quantitative Stock Analysis

Validea's Peter Lynch P/E/Growth Investor model assigned Centene Corp (CNC), a large-cap healthcare facilities stock, a 72% rating, which is below the 80% threshold typically indicating investment interest. While CNC passed tests for PEG ratio, EPS, and Total Debt/Equity, and showed neutral free cash flow and net cash position, it notably failed the Inventory to Sales criterion, impacting its overall fundamental and valuation score.

Analysis

Centene Corp (CNC), a large-cap value stock in the Healthcare Facilities sector, presents a mixed fundamental profile according to Validea's Peter Lynch-based P/E/Growth model, scoring 72%. This rating is below the 80% threshold that typically indicates investment interest from the strategy. The company demonstrates strengths in key areas, passing tests for its Yield Adjusted P/E to Growth (PEG) ratio, Earnings Per Share (EPS), and a favorable Total Debt/Equity ratio, suggesting it is reasonably priced relative to its growth and maintains a manageable leverage profile. However, these positive factors are counterbalanced by a notable 'FAIL' on the Inventory to Sales metric, which is a significant weakness under this specific analytical framework. Additionally, the company's Free Cash Flow and Net Cash Position are rated as 'NEUTRAL', indicating they are neither a source of strength nor a significant concern at present. The overall assessment points to a company with some attractive GARP characteristics that is ultimately held back from a strong endorsement by specific operational and cash-related metrics.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment

Overall Sentiment

mildly positive

Sentiment Score

0.25

Ticker Sentiment

CNC0.30
NDAQ0.00

Key Decisions for Investors

  • Investors interested in a GARP approach may find CNC's favorable PEG ratio and EPS performance attractive, but should weigh this against the model's overall score of 72%, which does not constitute a strong buy signal.
  • The 'FAIL' rating on the Inventory to Sales ratio warrants further due diligence to understand the underlying operational issues and potential impact on future margins before initiating or adding to a position.
  • Given the neutral readings on free cash flow and net cash position, investors should monitor these metrics in subsequent financial reports, as any significant change could materially alter the stock's fundamental thesis.